302 related articles for article (PubMed ID: 11373102)
1. Effect of primary treatment on survival in anaplastic thyroid carcinoma.
Besic N; Auersperg M; Us-Krasovec M; Golouh R; Frkovic-Grazio S; Vodnik A
Eur J Surg Oncol; 2001 Apr; 27(3):260-4. PubMed ID: 11373102
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
Yau T; Lo CY; Epstein RJ; Lam AK; Wan KY; Lang BH
Ann Surg Oncol; 2008 Sep; 15(9):2500-5. PubMed ID: 18581185
[TBL] [Abstract][Full Text] [Related]
3. Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002.
Chen J; Tward JD; Shrieve DC; Hitchcock YJ
Am J Clin Oncol; 2008 Oct; 31(5):460-4. PubMed ID: 18838882
[TBL] [Abstract][Full Text] [Related]
4. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups.
Heron DE; Karimpour S; Grigsby PW
Am J Clin Oncol; 2002 Oct; 25(5):442-6. PubMed ID: 12393980
[TBL] [Abstract][Full Text] [Related]
6. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy.
De Crevoisier R; Baudin E; Bachelot A; Leboulleux S; Travagli JP; Caillou B; Schlumberger M
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1137-43. PubMed ID: 15519785
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of anaplastic thyroid carcinoma. Our experience.
Palestini N; Brignardello E; Freddi M; Piovesan A; Pipitone Federico NS; Sisto G; Robecchi A
G Chir; 2010; 31(6-7):282-5. PubMed ID: 20646371
[TBL] [Abstract][Full Text] [Related]
10. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
11. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic thyroid carcinoma in ecuador: analysis of prognostic factors.
Pacheco-Ojeda LA; Martínez AL; Alvarez M
Int Surg; 2001; 86(2):117-21. PubMed ID: 11918236
[TBL] [Abstract][Full Text] [Related]
13. [Treatment and prognosis of anaplastic thyroid carcinoma].
Sun CZ; Chen FJ; Zeng ZY; Chen YF; Li QL; Guan Z; Tian SZ
Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1493-7. PubMed ID: 17349179
[TBL] [Abstract][Full Text] [Related]
14. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
15. Therapy of stage IV B anaplastic thyroid carcinoma: single institution experience.
Vrbic S; Pejcic I; Vrbic M; Filipovic S
J BUON; 2009; 14(1):41-4. PubMed ID: 19373945
[TBL] [Abstract][Full Text] [Related]
16. Treatment of 37 patients with anaplastic carcinoma of the thyroid.
Kobayashi T; Asakawa H; Umeshita K; Takeda T; Maruyama H; Matsuzuka F; Monden M
Head Neck; 1996; 18(1):36-41. PubMed ID: 8774920
[TBL] [Abstract][Full Text] [Related]
17. Childhood and adolescent thyroid carcinoma.
Grigsby PW; Gal-or A; Michalski JM; Doherty GM
Cancer; 2002 Aug; 95(4):724-9. PubMed ID: 12209714
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic thyroid carcinoma: a 50-year experience at a single institution.
McIver B; Hay ID; Giuffrida DF; Dvorak CE; Grant CS; Thompson GB; van Heerden JA; Goellner JR
Surgery; 2001 Dec; 130(6):1028-34. PubMed ID: 11742333
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
20. Anaplastic thyroid cancer: prevalence, diagnosis and treatment.
Chiacchio S; Lorenzoni A; Boni G; Rubello D; Elisei R; Mariani G
Minerva Endocrinol; 2008 Dec; 33(4):341-57. PubMed ID: 18923370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]